2m 2m 2m 2m 2m 2m 2m
GSK Sp ADR (GSK)
NYSE
$51.84+$1.10 (+2.17%)
Price as of Jun 23, 2026 12:41 PM EDT- $101.7BMarket Cap
- 37.62%1-Year Change
- Drug Manufacturers - GeneralIndustry
GSK Sp ADR (GSK)
$51.84+$1.10 (+2.17%)
GSK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $50.74 | ||
Change | +$0.07 (+0.14%) | ||
Open | $50.79 | ||
High | $51.17 | ||
Low | $50.59 | ||
Previous Close | $50.67 | ||
Volume | 3,735,159 | ||
30-Day Average Volume | 3,976,015 | ||
1-Week Change | -2.85% | ||
1-Month Change | -1.25% | ||
1-Year Change | 37.62% | ||
3-Year Change | 64.75% | ||
5-Year Change | 27.60% | ||
Fundamentals | |||
Shares Outstanding | 2.0B | ||
Total Assets | $61.1B | ||
Market Cap | $101.7B | ||
Enterprise Value | $101.3B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 3.63% | ||
Trailing Annual Dividend Yield | 3.55% | ||
Ex-Dividend Date | 05/15/2026 | ||
Last Split Factor | 4 : 5 | ||
Last Split Date | 07/19/2022 | ||
Earnings & Revenue
Annual Dividend Yield